In last trading session, Spruce Biosciences Inc (NASDAQ:SPRB) saw 0.35 million shares changing hands with its beta currently measuring 2.37. Company’s recent per share price level of $0.42 trading at -$0.01 or -1.20% at ring of the bell on the day assigns it a market valuation of $17.35M. That closing price of SPRB’s stock is at a discount of -1316.67% from its 52-week high price of $5.95 and is indicating a premium of 19.05% from its 52-week low price of $0.34.
For Spruce Biosciences Inc (SPRB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Spruce Biosciences Inc (NASDAQ:SPRB) trade information
Upright in the red during last session for losing -1.20%, in the last five days SPRB remained trading in the green while hitting it’s week-highest on Friday, 02/21/25 when the stock touched $0.42 price level, adding 5.83% to its value on the day. Spruce Biosciences Inc’s shares saw a change of 0.00% in year-to-date performance and have moved 2.39% in past 5-day. Spruce Biosciences Inc (NASDAQ:SPRB) showed a performance of 11.26% in past 30-days.
Spruce Biosciences Inc (SPRB) estimates and forecasts
This year revenue growth is estimated to fall -49.52% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 885k for the same. And 4 analysts are in estimates of company making revenue of 500k in the next quarter. Company posted 2.89M and 2M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -22.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 24.68% while estimates for its earnings growth in next 5 years are of 20.77%.
Spruce Biosciences Inc (NASDAQ:SPRB)’s Major holders
RIVERVEST VENTURE MANAGEMENT LLC is the top institutional holder at SPRB for having 2.94 million shares of worth $1.52 million. And as of 2024-06-30, it was holding 7.1449 of the company’s outstanding shares.
The second largest institutional holder is CARLYLE GROUP INC., which was holding about 2.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.0481 of outstanding shares, having a total worth of $1.52 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 638.56 shares of worth $0.27 million or 1.55% of the total outstanding shares. The later fund manager was in possession of 197.19 shares on Sep 30, 2024 , making its stake of worth around $82818.0 in the company or a holder of 0.48% of company’s stock.
